Tilray TLRY shares are trading higher Tuesday after Democratic Senators indicated they would push a marijuana reform bill.
Shares traded higher on Monday as well.
See also: How to Invest in Cannabis Stocks
Tilray, headquartered in Nanaimo, Canada, cultivates and sells medical and recreational cannabis through a portfolio of brands that include Canaca, Dubon, and Manitoba Harvest. The bulk of Tilray's sales are in Canada, but the company also sells CBD Products in the U.S. and exports medical cannabis globally from its production facilities in Canada and Portugal. Tilray also has a joint venture partnership with AB InBev to develop cannabis-infused drinks.
Tilray's stock was up 23.05% at $23.50. The stock has a 52-week high of $23.56 and a 52-week low of $2.43.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
